This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Teijin Pharma Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Jun Matsui in Nitric Oxide Administration
Introduction
Jun Matsui is a notable inventor based in Matsuyama, Japan. He has made significant contributions to the field of medical devices, particularly with his innovative approach to nitric oxide administration. His work is recognized for its potential impact on respiratory therapies.
Latest Patents
Matsui holds a patent for a nitric oxide administration device. This device includes a first flow path with a first intake port and an oxygen supply port. It features an oxygen generation unit that generates concentrated oxygen from air introduced via the first intake port. The generated concentrated oxygen is supplied via the oxygen supply port. Additionally, there is a second flow path branched from the first flow path, which includes an NO supply port. An NO generation unit is arranged in the second flow path, generating NO from gas distributed from the first flow path. The generated NO is supplied via the NO supply port. This innovative device has the potential to enhance therapeutic applications in medical settings.
Career Highlights
Jun Matsui is currently employed at Teijin Pharma Limited, where he continues to develop and refine medical technologies. His work at the company has positioned him as a key player in the advancement of healthcare solutions.
Collaborations
Matsui collaborates with talented individuals such as Rei Tamiya and Naoyuki Iida. These collaborations foster a creative environment that encourages innovation and the development of new technologies.
Conclusion
Jun Matsui's contributions to the field of nitric oxide administration highlight his innovative spirit and dedication to improving medical devices. His patent and ongoing work at Teijin Pharma Limited demonstrate the importance of collaboration and creativity in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile